日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Recombinant human thrombopoietin as a novel platelet-driven regulator accelerating hepatic regeneration in acute liver failure.

重组人血小板生成素作为一种新型血小板驱动调节剂,可加速急性肝衰竭中的肝脏再生。

Shen Yunzhi, Han Fengzheng, Wang Tao, Jing Li, Luo Ying, Ha Fushuang, Lu Yongping, Liang Jing

Myasthenia Gravis-Like Symptoms Following Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma: A Case Report

肝细胞癌免疫检查点抑制剂治疗后出现重症肌无力样症状:病例报告

Ha, Fushuang; Wang, Haoyu; Cai, Junjun; Liang, Jing; Liu, Hua

Value of Preoperative Systemic Immune-Inflammation Index and Albumin-Bilirubin Grade in Patients with Hepatocellular Carcinoma Undergoing Transarterial Embolization

术前全身免疫炎症指数和白蛋白-胆红素分级在接受经动脉栓塞治疗的肝细胞癌患者中的价值

Ha, Fushuang; Wang, Xue; Han, Tao; Jia, Kefeng; Wang, Sen; Song, Dezhao

Characteristics of acute kidney injury and its impact on outcome in patients with acute-on-chronic liver failure

急性肾损伤的特征及其对急性加重型慢性肝衰竭患者预后的影响

Huang, Yue; Cai, Junjun; Ha, Fushuang; Guo, Beichen; Xin, Shaojie; Duan, Zhongping; Han, Tao

Autotaxin: An Early Warning Biomarker for Acute-on-chronic Liver Failure.

自泌素:急性加重型慢性肝衰竭的早期预警生物标志物

Nie Caiyun, Zhang Lei, Chen Xiaobing, Li Ying, Ha Fushuang, Liu Hua, Han Tao